TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare blood vessel disease
Disease control CompletedThis study tested the drug upadacitinib in 12 adults with Takayasu arteritis that did not improve with standard treatments. The goal was to see if the drug could help control the disease by reducing inflammation in the blood vessels. Participants took the pill daily for 24 weeks,…
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Liu Tian • Aim: Disease control
Last updated Jun 12, 2026 12:06 UTC
-
Could a tiny dose of an alcohol addiction drug ease vasculitis symptoms?
Symptom relief CompletedThis study tested whether a low dose of naltrexone, a drug normally used for alcohol dependence, can improve physical health and quality of life in people with vasculitis (a group of rare blood vessel diseases). Sixty adults with different types of vasculitis took either the low …
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 02, 2026 11:57 UTC
-
Surgery may boost survival in rare artery disease
Knowledge-focused CompletedThis study looked at 78 people with Takayasu arteritis, a rare disease that causes severe narrowing of the main artery in the chest and belly. Researchers compared those who had surgery to fix the narrowing with those who received only medication. The goal was to see which approa…
Matched conditions: TAKAYASU ARTERITIS
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC